Local Dystrophin Restoration with Antisense Oligonucleotide PR0051VAN DEUTEKOM, Judith C; JANSON, Anneke A; DE KIMPE, Sjef J et al.The New England journal of medicine. 2007, Vol 357, Num 26, pp 2677-2686, issn 0028-4793, 10 p.Article

Local Dystrophin Restoration with Antisense Oligonucleotide PR0051PLAISIER, Emmanuelle; GRIBOUVAL, Olivier; DRACON, Michel et al.The New England journal of medicine. 2007, Vol 357, Num 26, pp 2687-2695, issn 0028-4793, 9 p.Article

An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule-1, in the treatment of chronic, unremitting pouchitisMINER, P. JR; WEDEL, M; BANE, B et al.Alimentary pharmacology & therapeutics. 2004, Vol 19, Num 3, pp 281-286, issn 0269-2813, 6 p.Article

Smart delivery of antisense oligonucleotides by anionic pH-sensitive liposomesFATTAL, Elias; COUVREUR, Patrick; DUBERNET, Catherine et al.Advanced drug delivery reviews. 2004, Vol 56, Num 7, pp 931-946, issn 0169-409X, 16 p.Article

Une classe de molécules attractives : les oligonucléotides thérapeutiquesFICHOU, Y; FEREC, C.Biofutur (Puteaux). 2007, Num 278, pp 36-39, issn 0294-3506, 4 p.Article

Displacement chromatography of anti-sense oligonucleotide and proteins using saccharin as a non-toxic displacerTUGCU, Nihal; DESHMUKH, Ranjit R; SANGHVI, Yogesh S et al.Reactive & functional polymers. 2003, Vol 54, Num 1-3, pp 37-47, issn 1381-5148, 11 p.Article

Locked nucleic acid (LNA) recognition of RNA: NMR solution structures of LNA :RNA hybridsPETERSEN, Michael; BONDENSGAARD, Kent; WENGEL, Jesper et al.Journal of the American Chemical Society. 2002, Vol 124, Num 21, pp 5974-5982, issn 0002-7863Article

Effect of hepatocyte growth factor on early human haemopoietic cell developmentRATAJCZAK, M. Z; MARLICZ, W; RATAJCZAK, J et al.British journal of haematology. 1997, Vol 99, Num 1, pp 228-236, issn 0007-1048Article

A Prospective Study in the Rational Design of Efficient Antisense Oligonucleotides for Exon Skipping in the DMD GeneALOYSIUS DWI PRAMONO, Zacharias; KENG BOON WEE; JIAN LI WANG et al.Human gene therapy. 2012, Vol 23, Num 7, pp 781-790, issn 1043-0342, 10 p.Article

A simple γ-backbone modification preorganizes peptide nucleic acid into a helical structureDRAGULESCU-ANDRASI, Anca; RAPIREDDY, Srinivas; FREZZA, Brian M et al.Journal of the American Chemical Society. 2006, Vol 128, Num 31, pp 10258-10267, issn 0002-7863, 10 p.Article

Multigene targeting with antisense oligodeoxynucleotides : An exploratory study using primary human leukemia cellsOPALINSKA, Joanna B; MACHALINSKI, Boguslaw; RATAJCZAK, Janina et al.Clinical cancer research. 2005, Vol 11, Num 13, pp 4948-4954, issn 1078-0432, 7 p.Article

Scalable membrane ion-exchange chromatography purification of an antisense oligonucleotideLAJMI, Ajay R.Pharmaceutical technology (2003). 2005, Vol 29, Num 5, pp 58-64, issn 1543-2521, 4 p.Article

The inhibition of angiogenesis by antisense oligonucleotides to clusterinJACKSON, John K; GLEAVE, Martin E; GLEAVE, Jacqueline et al.Angiogenesis (London). 2005, Vol 8, Num 3, pp 229-238, issn 0969-6970, 10 p.Article

Antisense oligonucleotidesKASHIHARA, N; MAESHIMA, Y; MAKINO, H et al.Experimental nephrology. 1998, Vol 6, Num 1, pp 84-88, issn 1018-7782Article

Activating the synthesis of progerin, the mutant prelamin A in Hutchinson―Gilford progeria syndrome, with antisense oligonucleotidesFONG, Loren G; VICKERS, Timothy A; DAVIES, Brandon S. J et al.Human molecular genetics (Print). 2009, Vol 18, Num 13, pp 2462-2471, issn 0964-6906, 10 p.Article

Type II/III Runx2/Cbfal is required for tooth germ developmentKOBAYASHI, Ieyoshi; KIYOSHIMA, Tamotsu; WADA, Hiroko et al.Bone (New York, NY). 2006, Vol 38, Num 6, pp 836-844, issn 8756-3282, 9 p.Article

Use of a chemically modified antisense oligonucleotide library to identify and validate Eg5 (kinesin-like 1) as a target for antineoplastic drug developmentROLLER, Erich; PROPP, Stephanie; GLAZER, Robert I et al.Cancer research (Baltimore). 2006, Vol 66, Num 4, pp 2059-2066, issn 0008-5472, 8 p.Article

Cellular penetration and antisense activity by a phenoxazine-substituted heptanucleotideFLANAGAN, W. M; WAGNER, R. W; GRANT, D et al.Nature biotechnology. 1999, Vol 17, Num 1, pp 48-52, issn 1087-0156Article

Oligonucleotide uptake in cultured keratinocytes: Influence of confluence, cationic liposomes, and keratinocyte cell typeWHITE, P. J; FOGARTY, R. D; MCKEAN, S. C et al.Journal of investigative dermatology. 1999, Vol 112, Num 5, pp 699-705, issn 0022-202XArticle

A Renaissance for Antisense Oligonucleotide Drugs in Neurology : Exon Skipping Breaks New GroundYOKOTA, Toshifumi; TAKEDA, Shinichi; LU, Qi-Long et al.Archives of neurology (Chicago). 2009, Vol 66, Num 1, pp 32-38, issn 0003-9942, 7 p.Article

ODNBase: a web database for antisense oligonucleotide effectiveness studiesGIDDINGS, Michael C; MATVEEVA, Olga V; ATKINS, John F et al.Bioinformatics (Oxford. Print). 2000, Vol 16, Num 9, pp 843-844, issn 1367-4803Conference Paper

Antisense therapy : Therapeutic magic bullet or theoretical dream ?TURNER, C.Clinical oncology (Springer. Print). 1997, Vol 9, Num 1, pp 54-58, issn 0936-6555Conference Paper

GS-101 Antisense Oligonucleotide Eye Drops Inhibit Corneal Neovascularization: Interim Results of a Randomized Phase II TrialCURSIEFEN, Claus; BOCK, Felix; DESCOHAND, Isabelle et al.Ophthalmology (Rochester, MN). 2009, Vol 116, Num 9, pp 1630-1637, issn 0161-6420, 8 p.Article

Challenges and Opportunities for Local and Systemic Delivery of siRNA and Antisense OligonucleotidesSEPP-LORENZINO, L; RUDDY, M. K.Clinical pharmacology and therapeutics. 2008, Vol 84, Num 5, pp 628-632, issn 0009-9236, 5 p.Article

Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and functionHAIFANG YIN; MOULTON, Hong M; SEOW, Yiqi et al.Human molecular genetics (Print). 2008, Vol 17, Num 24, pp 3909-3918, issn 0964-6906, 10 p.Article